These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24027830)

  • 1. [The role of epithelial to mesenchymal transition in chronic respiratory diseases].
    Liao CC; Chen YH
    Sheng Li Ke Xue Jin Zhan; 2013 Jun; 44(3):216-9. PubMed ID: 24027830
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelial Mesenchymal Transition in Respiratory Disease: Fact or Fiction.
    Knight DA; Grainge CL; Stick SM; Kicic A; Schuliga M
    Chest; 2020 Jun; 157(6):1591-1596. PubMed ID: 31952949
    [No Abstract]   [Full Text] [Related]  

  • 3. Knowledge translation: airway epithelial cell migration and respiratory diseases.
    Xiao H; Li DX; Liu M
    Cell Mol Life Sci; 2012 Dec; 69(24):4149-62. PubMed ID: 22718093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propolis inhibits TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells via PPARγ activation.
    Kao HF; Chang-Chien PW; Chang WT; Yeh TM; Wang JY
    Int Immunopharmacol; 2013 Mar; 15(3):565-74. PubMed ID: 23328619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells.
    Mikami Y; Yamauchi Y; Horie M; Kase M; Jo T; Takizawa H; Kohyama T; Nagase T
    Biochem Biophys Res Commun; 2012 Nov; 428(4):451-7. PubMed ID: 23131560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transforming growth factor-β in airway remodeling in asthma.
    Halwani R; Al-Muhsen S; Al-Jahdali H; Hamid Q
    Am J Respir Cell Mol Biol; 2011 Feb; 44(2):127-33. PubMed ID: 20525803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke.
    Milara J; Peiró T; Serrano A; Cortijo J
    Thorax; 2013 May; 68(5):410-20. PubMed ID: 23299965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell origins of smoking-induced airway epithelial disorders.
    Shaykhiev R; Crystal RG
    Cell Cycle; 2014; 13(3):341-2. PubMed ID: 24335435
    [No Abstract]   [Full Text] [Related]  

  • 9. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
    Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
    Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous lung stem cells and contribution to disease.
    Snyder JC; Teisanu RM; Stripp BR
    J Pathol; 2009 Jan; 217(2):254-64. PubMed ID: 19039828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β activation and lung fibrosis.
    Tatler AL; Jenkins G
    Proc Am Thorac Soc; 2012 Jul; 9(3):130-6. PubMed ID: 22802287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma.
    Royce SG; Tan L; Koek AA; Tang ML
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):238-46. PubMed ID: 19354071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis.
    Kumar RK; Herbert C; Foster PS
    Clin Exp Allergy; 2004 Apr; 34(4):567-75. PubMed ID: 15080809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic mechanisms and the the clinical aspects of secondary pulmonary hypertension and respiratory system diseases].
    Carratu' L; Marangio E; Cuomo A; Pesci A
    Torace; 1979 Mar; 22(1):50-71. PubMed ID: 400054
    [No Abstract]   [Full Text] [Related]  

  • 15. The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases.
    Chen Y; Wang R
    Respir Physiol Neurobiol; 2012 Nov; 184(2):130-8. PubMed ID: 22476058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis.
    Felton VM; Inge LJ; Willis BC; Bremner RM; Smith MA
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):523-30. PubMed ID: 21163500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease: physiopathology in the context of lung growth.
    Nathan N; Thouvenin G; Fauroux B; Corvol H; Clement A
    Paediatr Respir Rev; 2011 Dec; 12(4):216-22. PubMed ID: 22018034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease?
    Bassiouni A; Naidoo Y; Wormald PJ
    Laryngoscope; 2012 Jan; 122(1):225-9. PubMed ID: 22183638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous stimulation with TGF-β1 and TNF-α induces epithelial mesenchymal transition in bronchial epithelial cells.
    Kamitani S; Yamauchi Y; Kawasaki S; Takami K; Takizawa H; Nagase T; Kohyama T
    Int Arch Allergy Immunol; 2011; 155(2):119-28. PubMed ID: 21196756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway epithelial cells in asthma.
    Préfontaine D; Hamid Q
    J Allergy Clin Immunol; 2007 Dec; 120(6):1475-8. PubMed ID: 17980414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.